Mike Yan Yeung - 16 Mar 2026 Form 3 Insider Report for Zepp Health Corp (ZEPP)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
16 Mar 2026, 06:07:25 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mike Yan Yeung

Key filing fact

Mike Yan Yeung filed Form 3 for Zepp Health Corp (ZEPP) on 16 Mar 2026.

Key facts

  • This page summarizes Mike Yan Yeung's Form 3 filing for Zepp Health Corp (ZEPP).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 16 Mar 2026, 06:07.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002084331 Primary reporting owner

Yeung Mike Yan

Relationship
Chief Operating Officer, Director
Address
1551 MCCARTHY BLVD, SUITE 107, MILPITAS
Signature
/s/ Mike Yan Yeung
Signature date
16 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ZEPP holding

Class A ordinary shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
853,700
Date
16 Mar 2026
Ownership
Direct
ZEPP holding

American depositary shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
100,913
Date
16 Mar 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Each American depositary share ("ADS") represents 16 Class A ordinary shares, par value US$0.0001 per share.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .